"I've always said if a company can find a way [to help people lose weight], it's a huge market," he said
"Todays approval is another demonstration of what the FDA can accomplish when we try bold new things." The higher-dose GLP-1 is indicated to "reduce excess body weight and maintain weight reduction long-term in adults with obesity, or overweight with at least one weight-related condition," per the FDA's statement
other changes are subtle, slow, and only obvious once you look back
The statement highlights a conflict between the parties about what should be required to file a lawsuit
Oxandrolone was originally developed for medical use in treating muscle wasting conditions, severe burns, and osteoporosis
A: Each soap is securely packaged to maintain its quality